Current Opinion in Immunology

Papers
(The median citation count of Current Opinion in Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection471
Oncogenic viruses, cancer biology, and innate immunity121
The future of vaccination in Latin America: learning from the COVID-19 pandemic115
An easy pill to swallow: oral recombinant vaccines for the 21st century93
Can we cure primary biliary cholangitis?88
Can juvenile idiopathic arthritis be cured?66
TAP-ing into the cross-presentation secrets of dendritic cells65
Mechanistic insights into epigenetic contributions to psoriasis pathogenesis and their clinical implications62
T cells in Sjögren’s disease: update on their role in salivary gland pathogenesis and treatment60
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation60
Principles and practical applications of structure-based vaccine design59
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity57
Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models56
Nutritional modulation of antitumor immunity56
The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasis51
Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity46
Commander-in-chief: monocytes rally the troops for defense against aspergillosis43
B cell–targeted therapies in autoimmune skin disease: current advances and challenges37
Can we cure Behçet syndrome?36
Innate antiviral immunity and immunometabolism in hepatocytes34
Complement in antiphospholipid syndrome, time to target?34
Necroptosis in immunity, tissue homeostasis, and cancer34
A critical look at observational studies33
Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection33
Can sarcoidosis be cured?32
Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration32
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules32
Regulation of MHC class II and CD86 expression by March-I in immunity and disease31
Metabolism and macrophages in the tumor microenvironment30
Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking29
Mapping and modelling human B cell maturation in the germinal centre29
Can we cure bullous skin diseases?28
Immunological scars after cure of hepatitis C virus infection: Long‐HepC?28
Patterns of bacterial viability governing noncanonical inflammasome activation28
The power of genetics in decoding Sjögren’s disease: current status and future development28
Editorial Board28
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance27
Animal models of autoimmune encephalitis26
Implication of epigenetic factors in development and recurrence of psoriasis26
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation25
Editorial Board24
Nucleic acid triggers of autoimmunity and autoinflammation23
Harnessing IgG Fc glycosylation for clinical benefit23
Use of synthetic data, a novel paradigm for immunopathology23
Game of Omes: ribosome profiling expands the MHC-I immunopeptidome23
Thetis cells: regulators of intestinal immune tolerance22
Outer membrane vesicle-based intranasal vaccines22
Can we cure antiphospholipid syndrome?22
Resolving adjuvant mode of action to enhance vaccine efficacy22
HLA-B27 as a potential target for the cure of axial spondyloarthritis21
Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans21
Killing in self-defense: proapoptotic drugs to eliminate intracellular pathogens21
Immune responses to Toxoplasma gondii21
Epigenetics: the link between environmental exposures and autoimmune diseases21
The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention21
Rheumatoid arthritis — the role of T cells in this complex systemic autoimmune disease20
New insights into the mechanisms regulating plasma cell survival and longevity20
Treating sarcoidosis: when less is more20
Editorial Board20
Won’t you be my neighbor? Control of the immune response by stromal and immune cell microenvironments within the lymph node20
A throwback on 25 years in pannexin research19
Intracellular complement in monocytes and macrophages: emerging roles19
Neuroimmune crosstalk in the skin: a delicate balance governing inflammatory processes19
B cell memory of Immunoglobulin E (IgE) antibody responses in allergy19
Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis18
Inborn errors of human transcription factors governing IFN-γ antimycobacterial immunity18
Mechanisms and risk factors for perinatal allergic disease18
Clinical trials and new therapies in Sjögren’s disease18
Can we cure lupus?18
New autoantibodies in Sjögren's disease18
‘Can we cure IgG4-related diseases?’17
Immune dyshomeostasis in lifestyle-associated diseases: a new paradigm for personalized medicine and prevention17
Regulation of inflammation by Interleukin-10 in the intestinal and respiratory mucosa17
Metabolomic signaling in sarcoidosis pathogenesis17
Multiple sclerosis: a disease or a syndrome?17
Drivers and shapers of macrophages specification in the developing brain16
A critical look at animal and cellular models in autoinflammatory diseases16
Immunometabolic regulation of germinal centers and its implications for aging16
Tumor immune evasion through loss of MHC class-I antigen presentation16
Regulation of type I and type III interferon induction in response to pathogen sensing16
Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment16
Why we need to maintain a critical view on big data and artificial intelligence predictions15
Eliciting or silencing complement activation: strategies for optimizing monoclonal antibodies functions15
Advances and challenges in investigating B-cells via single-cell transcriptomics15
Challenges in diagnosis of sarcoidosis15
Red blood cell alloimmunization immunogenetic risk factor15
The role of epigenetics in inflammatory memory15
Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility14
New insights and approaches for analyses of immunopeptidomes14
The role of epigenetic modifications in systemic autoinflammatory diseases14
Autoimmunity, epitope analysis, and molecular mimicry14
Ocular sarcoidosis: from clinical signs to targeted interventions14
Defining the niche for stem-like CD8+ T cell formation and function13
IFNε, IFNω and IFNλ: interferons defending the mucosa13
TH17 cell immune adaptation13
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells13
PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis12
Layers of defense: protection from respiratory viruses by epithelial-intrinsic immunity12
Inherited human ZNF341 deficiency12
The choroid plexus in inflammatory and degenerative diseases of the central nervous system12
HyperIgE in hypomorphic recombination-activating gene defects12
Differential signaling by type-I and type-III interferons in mucosa12
Addressing unmet needs in rheumatoid arthritis: the challenge of translating multi-omics into precision therapies12
The thymoproteasome in shaping the CD8+ T-cell repertoire12
Functional flexibility and plasticity in immune control of systemic Salmonella infection12
Curing inflammatory bowel diseases: breaking the barriers of current therapies– emerging strategies for a definitive treatment12
Local complement inhibition by selective precision-targeted therapies11
T follicular helper cells in food allergy11
Editorial overview: Special section neuroimmunology: Neuroimmune interactions in health and disease11
From metabolomics to transfusion-associated immunomodulation11
Molecular insights into metabolite antigen recognition by mucosal-associated invariant T cells11
Inflammation induced by lipid mediators and protein from transfusion products11
Human inborn errors of type I interferon–independent intrinsic immunity in nonleukocytic cells11
Editorial Board11
A liver–mitochondria–immune axis in Parkinson’s disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson’s disease11
Harnessing dendritic cell diversity in cancer immunotherapy11
Microbiota and B-1 B cell repertoire development in mice10
Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases10
Inflammasomes and their role in PANoptosomes10
The role of different aPL subpopulations in the lupus anticoagulant phenomenon10
Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis10
Spontaneous and induced adaptive immune responses in Alzheimer’s disease: new insights into old observations10
The role of intestinal bacteria in promoting tolerance to food10
Mpox virus immunology: exploring links to autoimmune diseases10
Biochemical and cytokine environment in skeletally immature patients after traumatic knee injuries10
Immunosenescence and human healthspan. Lessons from centenarians9
Can we cure Sjogren’s disease? Unmet needs and raising questions in the era of Precision medicine9
Potential immune consequences of cold-stored platelet transfusion9
B-cell antigen presentation in central nervous system autoimmunity9
Editorial overview: Getting the house in order: Cell-intrinsic mechanisms of innate immune defence9
The tumor-driven antibody-mediated immune response in cancer9
From disease to syndrome: the evolution of Parkinson’s as a heterogeneous entity9
Spatiotemporal and cell-state control of antigen presentation during tolerance and immunity9
Pulmonary transfusion reactions as an immunological spectrum disorder9
Mapping the B-cell axis in Sjögren’s disease: repertoire, microenvironment, and potential routes to precision treatment9
Multilevel approaches to immunization equity9
Gut microbiota in pathogenesis and therapeutic potentials in rheumatoid arthritis9
On or within: spatial determinants of antigen handling in the nasal turbinates9
The role of the antigen processing machinery in the regulation and trafficking of intracellular -Toll-like receptor molecules9
Extracellular vesicle impact on immunity following blood transfusion9
Editorial Board9
Elderly-onset rheumatoid arthritis as a distinct entity: mechanisms, manifestations, and treatment8
The indole-brain connection: neuroimmune mechanisms and therapy8
Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus8
Editorial Board8
TRPM7 channel-kinase in immunity: new frontiers of an emerging therapeutic target8
Chemokines that govern T cell activity in tumors8
B cells spatial organization defines their phenotype and function in cancer “Tell me with whom you consort, and I will tell you who you are” ― Goethe8
Toward indole postbiotics precision therapy via AI-powered drug delivery technologies8
Autoimmune-related adverse events induced by immune checkpoint inhibitors8
Immunotherapy for pemphigus and bullous pemphigoid8
The role of linked recognition and B cell precursor frequency in alloimmunization to transfused RBCs8
Lymphatic endothelial cells actively shape immune responses in the lungs8
Human guanylate-binding proteins in intracellular pathogen detection, destruction, and host cell death induction8
A critical look at disease classification/diagnosis criteria in rheumatology8
Major histocompatibility complex class I assembly within endolysosomal pathways8
Carbohydrate metabolism in supporting and regulating neutrophil effector functions8
The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design8
Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions8
In search of the cell biology for self- versus non-self- recognition8
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity8
SARS-CoV-2 and chronic kidney disease: challenges and future directions8
Moving beyond the Janus kinase signaling kinases in the pathogenesis and treatment of psoriasis and psoriatic arthritis8
Antiviral responses in peripheral and brain neurons8
The role of interferon in the thymus7
Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus7
Insights into the pathogenesis of allergic disease from dedicator of cytokinesis 8 deficiency7
T cell immunity to cytomegalovirus infection7
Editorial Board7
Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms7
Turning foes into permissive hosts: manipulation of macrophage polarization by intracellular bacteria7
Advances in treatment of psoriatic arthritis: current guidelines and emerging therapies7
Structure–function of type I and III interferons7
Fuelling B cells: dynamic regulation of B cell metabolism7
Decoding the complexity of intestinal immunity with spatial transcriptomics7
Two for the price of one: itaconate and its derivatives as an anti-infective and anti-inflammatory immunometabolite7
From sensing to shaping: microglial responses in the pathogenesis of viral encephalitis7
Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines6
The role of stromal cell immunobiology in understanding and managing Sjögren’s disease6
Tissue-specific proteasomes in generation of MHC class I peptides and CD8+ T cells6
Immunological insights in the treatment of chronic hepatitis B6
Editorial Board6
Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms6
Developments in oral enterotoxigenic Escherichia coli vaccines6
Regulatory T cells in the context: deciphering the dynamic interplay with the tissue environment6
Minor salivary gland biopsy in Sjogren’s disease: a diagnostic and prognostic tool toward precision medicine6
The role of allergen-specific regulatory T cells in the control of allergic disease6
T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease6
Move and countermove: the integrated stress response in picorna- and coronavirus-infected cells6
Nr4a nuclear receptors: markers and modulators of antigen receptor signaling6
T cell–B cell interactions in human autoimmune diseases6
Tipping the balance: innate and adaptive immunity in mitochondrial disease6
Optimizing patient-reported outcomes for sarcoidosis6
Editorial Board6
Patterns and trends in sarcoidosis: an epidemiological perspective6
Epithelial-immune interactions govern type 2 immunity at barrier surfaces6
Metabolic adaptations of ILC2 and Th2 cells in type 2 immunity6
Beyond ion flux: the potassium channel KV1.3 and its regulatory function in neutrophils6
Metabolic footprint and logic through the T cell life cycle6
Lymphatic messengers: Non-antigen soluble mediators from diseased tissues to draining lymph nodes5
The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases5
Determinants of persistent Salmonella infections5
Mapping economic outcomes: how biosimilars enhance access to health systems in Latin America and the Caribbean5
Editorial overview: Autoimmunity 20225
Advances in genetic–immunological targeted therapies for psoriasis5
When the lung is at risk: diagnosis, manifestations, and complications of pulmonary sarcoidosis5
C1 inhibitor: from complement system to bradykinin angioedema5
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects5
Neuroimmune recognition of allergens5
Spatial omics of immunity: Mapping cellular landscapes in tissue microenvironments5
From genes to granulomas: the genetic blueprint of sarcoidosis5
Evolution and prospects for the definition of clinically useful endpoints in Sjögren disease5
Systems biology approaches to unravel lymphocyte subsets and function5
Editorial overview: Innate immunity – 2023: Just in time defense5
Immunological complications of blood transfusion: current insights and advances4
Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren’s disease4
Recent progress in understanding of allergic transfusion reaction4
Pharma — manufacturing: the unappreciated and overlooked indispensable skill4
Functional subsets of tumor-specific CD8+ T cells in draining lymph nodes and tumor microenvironment4
Principles of bacterial innate immunity against viruses4
Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and …guilty4
Raynaud’s phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancy4
Hot topics in the antiphospholipid syndrome4
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?4
Editorial Board4
The antiviral state of the cell: lessons from SARS-CoV-24
More X’s, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity4
Diet-derived microbial metabolites as regulators of immune function4
A global perspective on autoimmunity and immunodeficiency: exploring geoepidemiology trends4
CD1 displays its own negative regulators4
Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes4
Help me help you: emerging concepts in T follicular helper cell differentiation, identity, and function4
Tuberculosis as an unconventional interferonopathy4
Imaging the T-cell receptor: new approaches, new insights4
Nasal vaccines for pertussis4
Insights into platelet post-transfusional human leukocyte antigen I immunization4
Mitochondrial reactive oxygen species: double agents in Mycobacterium tuberculosis infection4
0.42908596992493